Is BaaS still investable after Synapse?

Yes but selectively. Well-capitalized survivors (Unit, Treasury Prime, Synctera, Column, Cross River, Lead Bank sponsor model) + own-charter plays (Column, Lead, Grasshopper) + vertical BaaS (embedded lending, payroll, tax, insurance) + international (Swan, Griffin, Nium, Rapyd) are investable. Generic 'issue cards via API' with single sponsor bank is not.

Own bank charter or sponsor model?

Own charter (Column model, Lead partial) eliminates sponsor concentration risk but takes 3-5 years + $50-100M + de novo bank approval (rare). Sponsor model is faster but requires 2+ sponsor banks + backup + program-by-program approval. Most Series B+ BaaS platforms are pursuing hybrid (multi-sponsor + own charter path).

Strategic acquisition by banks (JPMorgan, BAML, Wells, Citi, USBank, Capital One, Truist, PNC), payments (Stripe, Adyen, PayPal, Block, Fiserv, FIS, Global Payments), or networks (Visa, Mastercard, Amex, Discover). IPO possible for category leader ($200-500M ARR + own charter). Marqeta precedent (IPO 2021 at $17B, now ~$3B). Consolidation likely 2026-2028 as survivors buy distressed peers.

Banking-as-a-Service Fundraising Guide (2026)

How BaaS platforms and sponsor-bank enablers raise capital in 2026 after Synapse collapse, Evolve consent orders.

Raising Capital for Banking-as-a-Service & Embedded Finance Platforms

BaaS survived the 2023-2025 reset (Synapse bankruptcy trapping $265M customer funds, Evolve Bank + Blue Ridge + Metropolitan + Cross River consent orders, FDIC + OCC + Fed joint third-party risk management guidance, 60%+ of sponsor banks pausing new fintech partnerships) and re-emerged in 2026 as a smaller, more regulated, more mature category. Unit, Treasury Prime, Synctera, Column (bank + BaaS), Cross River, Bond (shut down), Bond-adjacent, Rize (acquired by Fiserv), Increase, Modern Treasury (payment ops adjacent), Highnote, Marqeta, Lithic, Galileo (SoFi), Adyen Issuing, Stripe Issuing, Extend, Cardless, Deserve, Sutton, Piermont, Lead Bank, First Internet, Grasshopper, Choice, Coastal Community, plus international (Solaris EU, Swan EU, Griffin UK, Modulr UK, ClearBank UK, Railsr/Railsbank restructured, Weavr, Bnkbl, Toqio, Belvo Money LatAm, Nium, Rapyd) navigate a landscape where sponsor bank partnership is the gating question. Investors want proven compliance track record + sponsor bank relationships that survived 2023-2025 + real revenue + program-manager BSA/AML program — not another 'issue debit cards via API' pitch.

Why 2026 is different (post-Synapse)

Synapse bankruptcy (Apr 2024) trapped $265M in FBO accounts with reconciliation gaps between Synapse ledger + partner banks (Evolve, American Bank, AMG, Lineage). FDIC + Fed + OCC issued joint third-party risk management guidance. Evolve, Blue Ridge, Metropolitan, Cross River, Choice, Piermont all took consent orders 2023-2025. 60%+ of sponsor banks paused new fintech onboarding. Bond shut down (Aug 2023). Railsr (UK) restructured. Solaris (EU) took distressed funding. Result: category consolidated to compliance-first, well-capitalized survivors. Investors now want proven survival + sponsor diversity + own compliance program + optional own charter path — not the 2021 'move fast' BaaS pitch.

Realistic capital stack

Seed: $5-20M. Series A: $25-100M. Series B: $75-300M. Reference: Unit (~$170M+ raised), Treasury Prime (~$60M+ raised), Synctera (~$50M+ raised), Column (bootstrap → $50M+), Marqeta (public, $8B+ market cap), Lithic (~$100M+ raised), Highnote (~$100M+ raised), Alloy (~$200M+ raised), Modern Treasury (~$180M+ raised), Solaris (~$500M+ raised, distressed), Swan (~$100M+ raised), Griffin (~$40M+ raised, licensed UK bank), Nium (~$300M+ raised), Rapyd (~$770M+ raised). Category is smaller + more concentrated than 2021 boom projected.

Common failure modes

Single sponsor bank dependency (Synapse lesson). Underinvesting in compliance (BSA/AML + SAR + KYC is table stakes). Ignoring reconciliation + FBO account discipline (Synapse root cause). Overpromising to fintech programs without sponsor commitment. Pursuing programs sponsor bank won't approve (crypto, cannabis, offshore, high-risk). Building without dedicated CCO + BSA officer. Underestimating consent order recovery cost + timeline (12-24 months + $10-30M). Skipping SOC 2 + PCI DSS + ISO 27001.

Frequently asked questions

Is BaaS still investable after Synapse?: Yes but selectively. Well-capitalized survivors (Unit, Treasury Prime, Synctera, Column, Cross River, Lead Bank sponsor model) + own-charter plays (Column, Lead, Grasshopper) + vertical BaaS (embedded lending, payroll, tax, insurance) + international (Swan, Griffin, Nium, Rapyd) are investable. Generic 'issue cards via API' with single sponsor bank is not.
Own bank charter or sponsor model?: Own charter (Column model, Lead partial) eliminates sponsor concentration risk but takes 3-5 years + $50-100M + de novo bank approval (rare). Sponsor model is faster but requires 2+ sponsor banks + backup + program-by-program approval. Most Series B+ BaaS platforms are pursuing hybrid (multi-sponsor + own charter path).
Realistic exit?: Strategic acquisition by banks (JPMorgan, BAML, Wells, Citi, USBank, Capital One, Truist, PNC), payments (Stripe, Adyen, PayPal, Block, Fiserv, FIS, Global Payments), or networks (Visa, Mastercard, Amex, Discover). IPO possible for category leader ($200-500M ARR + own charter). Marqeta precedent (IPO 2021 at $17B, now ~$3B). Consolidation likely 2026-2028 as survivors buy distressed peers.

Related fundraising verticals (40)

Investor directory · Fundraising library · Articles A–Z · Company funding database